|
SRPK1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.483800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.964200E-02 |
| Normal-vs-Stage2 |
3.715700E-02 |
| Normal-vs-Stage3 |
1.151390E-01 |
| Normal-vs-Stage4 |
4.192200E-01 |
| Stage1-vs-Stage2 |
3.566000E-01 |
| Stage1-vs-Stage3 |
8.610200E-01 |
| Stage1-vs-Stage4 |
6.688000E-01 |
| Stage2-vs-Stage3 |
5.199600E-01 |
| Stage2-vs-Stage4 |
3.241600E-01 |
| Stage3-vs-Stage4 |
6.515400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.002580E-01 |
| Normal-vs-AfricanAmerican |
7.310600E-01 |
| Normal-vs-Asian |
8.553700E-02 |
| Caucasian-vs-AfricanAmerican |
5.475400E-01 |
| Caucasian-vs-Asian |
5.888400E-01 |
| AfricanAmerican-vs-Asian |
3.056600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.257700E-02 |
| Normal-vs-Female |
8.003900E-02 |
| Male-vs-Female |
4.276000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.127800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.031890E-02 |
| Normal-vs-Age(61-80Yrs) |
1.516390E-01 |
| Normal-vs-Age(81-100Yrs) |
8.454400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.290170E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.474600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.541800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.724600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.133800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.657600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.210800E-01 |
| Classical-VS-Follicular |
2.01489999999138E-05 |
| Classical-VS-Other |
2.309200E-01 |
| Classical-VS-Normal |
4.641000E-01 |
| Tall-VS-Follicular |
1.576090E-02 |
| Tall-VS-Other |
2.616800E-01 |
| Tall-VS-Normal |
9.171800E-01 |
| Follicular-VS-Other |
8.170800E-01 |
| Follicular-VS-Normal |
2.002400E-04 |
| Other-VS-Normal |
8.934000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.357600E-03 |
| Normal-vs-N1 |
4.518500E-02 |
| N0-vs-N1 |
8.173600E-01 |
|
|
